4 ms·
I'd like to point out that -- as much as I'm sure most people love 23andMe -- it's not really a scrappy start-up. It's a nearly 8 year old company which has re
by saalweachter 13y ago
I'd like to point out that -- as much as I'm sure most people love 23andMe -- it's not really a scrappy start-up. It's a nearly 8 year old company which has received something like a hundred million in funding.
So this isn't really a case of the gov't stomping on the little guy before he has a chance to grow; 23andMe has had its chance to grow into a fairly big deal, and now it's time to start playing by the rules.
- ig1 13y agoThe average drug costs around a billion dollars to bring to market and decades in development and approval. 23andme might not be a small fish by internet standards, but they are by medical industry standards.
- icegreentea 13y agoBut 23andme do not make drugs. They do diagnostic tests. The cost of development for those are much lower. 23andme aren't giants in that field for sure, but they're pretty big. It's absolutely nonsensical to compare them to a drug company.
- VLM 13y ago"They do diagnostic tests." More specifically they are busted for interpreting diagnostic tests not doing the tests. If they were two cooperating companies, and one did tests and squirted out results and the other sold diagnostic and interpretive services, the diagnostic services company would be busted but the test company would not be in trouble, as I interpret it at this time. Skip all the exotic genetic issues and think about personal experiences with something boring, like blood pressure. No legal problem with testing someones blood pressure and giving them numerical results and maybe a medically sane set of typical ranges. My local pharmacy has a machine that does it for free. However, it would be a big issue for a non-MD using that data to diagnose high blood pressure, or a high likelihood of it anyway, then providing some treatment plans. The issue seems to be selling services. If they just did testing, and provided a free downloadable immense data set and some statistical analysis tools and let the user come up with their own interpretations, they'd probably be in the clear (at least with respect to this individual problem). Now having a cloud service to hold the data and do the math is getting gray area ish but probably still OK as long as its the end user drawing the conclusions and not "the company" drawing the conclusions.
- jrochkind1 13y ago> Skip all the exotic genetic issues and think about personal experiences with something boring, like blood pressure. No legal problem with testing someones blood pressure and giving them numerical results and maybe a medically sane set of typical ranges. Actually, the device used to take the blood pressure reading, if I understand things right, did have to be approved by the FDA. The FDA's letter keeps referring to 23andme as a 'device', so it seems like the FDA's authorization/responsibility is specifically to regulate devices rather than services, actually, but they've decided 23andme can be technically classified as a 'device' under the relevant laws/regulations. If it was instead considered a 'service'... I wonder if there'd instead be a problem with practicing medicine without a license, if it's not MD's who are providing the 'service'!
- VLM 13y ago"the device used to take the blood pressure reading, if I understand things right, did have to be approved by the FDA" that is true, the FDA would bust a mfgr of a device that claimed to report blood pressure but instead did astrology. This specific example of 23andme is, as near as I can tell, getting busted for interpreting the results, not for using 'cat /dev/urandom' to generate the results and then interpreting them. Kind of like the same FCC that gets excited about out of band RF interference also got sorta excited by janet jackson's halftime show.
- judk 13y agoHow did you use both FDA and FCC correctly and then fail to notice they are not the same word?
- ajcarpy2005 13y agoHe didn't fail to notice they're different agencies. He is asserting that they both (being both government agencies) have each been inconsistent in their regulation.
- jrochkind1 13y ago
- kmfrk 13y agoIt was also co-founded by Sergey Brin's former wife.
- maratd 13y ago> So this isn't really a case of the gov't stomping on the little guy Last time I checked, the US federal government had an annual funding rate of $3.45 trillion compared to "a hundred million in funding" total for 23andMe. So yeah, government stomping on the little guy definitely fits the picture. Then again, it would fit the picture no matter who the government decided to stomp on. Perhaps we should focus on less stomping and on more cooperative behavior?
- gress 13y agoBy your argument any action the US government takes against anyone is 'stomping on the little guy'. How is a generic anti-government argument relevant here?
- FireBeyond 13y agoThat's disingenuous. The FDA's 2012 budget was $4.3B. The fact that our government chooses to pour $1/2T into the military, that has very little sway on this.
- wissler 13y agoMake no mistake -- after having stomped on this "not little guy", any new little guy that comes along is definitely going to get stomped on. Which of course means that no new little guys are going to come along. This is the process whereby established players obtain a monopoly. In other words, what doesn't kill 23andMe will make it stronger.